Editorial comment: Low-dose or moderate-dose anticoagulation: dream or hope for stroke prevention?
Hennerici
M G
MG
D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002545:Brain Ischemia / Q000150:complications / Q000517:prevention & control; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D019934:International Normalized Ratio / Q000592:standards / Q000706:statistics & numerical data; D018570:Risk Assessment; D020521:Stroke / Q000150:complications / Q000517:prevention & control*; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin; D001241:Aspirin